DDW Editor Reece Armstrong speaks to Michelle Carlson about overall advances in genomics and the integration of emerging technologies to create more drug discovery and development opportunities.  RA: How is long-read sequencing enabling greater clinical research in genomics? MC: Short-read sequencing is effective for identifying single-nucleotide mutations and other small variants that can cause genetic disease. However, many conditions stem from […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!